Processa Pharmaceuticals, Inc. Stock
Stocks
PCSA
US74275C4033
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Nasdaq
04:00:00 2026-10-15 pm EDT
|
5-day change | 1st Jan Change | ||
| 1.680 USD | +4.02% |
|
+24.44% | -41.67% |
| Market Cap | 5.41M 4.83M 4.49M 4.08M 7.69M 513M 7.82M 53.94M 21.11M 268M 20.31M 19.88M 856M | P/E 2024 |
-0.23x | P/E 2025 | -0.28x |
|---|---|---|---|---|---|
| Enterprise Value | -124K -111K -103K -93.44K -176K -11.73M -179K -1.23M -483K -6.12M -465K -455K -19.58M | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
85.18% | Yield 2024 * |
-
| Yield 2025 | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| PCSA | Delayed | |
CBOE
| PCSA | Real-time |
Last Transcript: Processa Pharmaceuticals, Inc.
| 1 day | +4.02% | ||
| 1 week | +24.44% | ||
| Current month | +2.44% | ||
| 1 month | -14.14% | ||
| 3 months | -29.71% | ||
| 6 months | -43.24% | ||
| Current year | -41.67% |
| 1 week | 1.04 |  | 1.98 |
| 1 month | 1.04 | | 2.02 |
| Current year | 1.04 | | 3.8 |
| 1 year | 1.04 | | 10.84 |
| 3 years | 1.04 | | 450 |
| 5 years | 1.04 | | 4,065 |
| 10 years | 1.04 | | 125,195.11 |
| Manager | Title | Age | Since |
|---|---|---|---|
George Ng
CEO | Chief Executive Officer | 52 | 2023-08-07 |
Patrick Lin
IRC | Investor Relations Contact | 60 | 2011-03-28 |
Wendy Guy
ADM | Chief Administrative Officer | 61 | 2017-10-03 |
| Director | Title | Age | Since |
|---|---|---|---|
David Young
CHM | Chairman | 73 | 2011-03-28 |
Justin Yorke
CHM | Chairman | 60 | 2022-08-15 |
Geraldine Pannu
BRD | Director/Board Member | 56 | 2020-02-12 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/8/26 | Exercice | Chief Executive Officer | 3,200 | 0.1156% | ||
| 7/26/26 | Other | Chief Financial Officer | 11,883 | 0.4293% | ||
| 7/26/26 | Other | Chief Executive Officer | 9,384 | 0.3390% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.02% | +24.44% | -83.60% | -99.40% | 5.41M | |
| +0.21% | -7.67% | +61.07% | +71.32% | 68.92B | |
| +1.66% | -9.54% | +10.39% | +60.04% | 51.9B | |
| +3.14% | +4.61% | +15.36% | +44.42% | 48.73B | |
| +3.45% | +4.70% | +33.44% | +36.21% | 43.13B | |
| -2.20% | +0.61% | +281.88% | +454.69% | 41.48B | |
| +6.43% | +6.84% | +18.32% | +115.06% | 39.96B | |
| +1.28% | -0.76% | +12.67% | +45.10% | 30.6B | |
| -2.21% | -14.22% | +40.33% | -0.94% | 26.01B | |
| +1.74% | -2.02% | -13.55% | -6.98% | 22.27B | |
| Average | +1.73% | -1.88% | +37.63% | +71.95% | 37.3B | |
| Weighted average by Cap. | +1.56% | -3.31% | +54.95% | +97.63% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -11.85M -10.58M -9.83M -8.94M -16.82M -1.12B -17.13M -118M -46.2M -586M -44.47M -43.53M -1.87B | -13.56M -12.11M -11.25M -10.24M -19.26M -1.28B -19.6M -135M -52.89M -670M -50.9M -49.82M -2.14B |
| Net Debt | -1.12M -998K -927K -844K -1.59M -106M -1.62M -11.14M -4.36M -55.24M -4.19M -4.11M -177M | -5.54M -4.94M -4.59M -4.18M -7.86M -524M -8M -55.18M -21.59M -274M -20.78M -20.34M -876M |
Employees
12
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-15 | $1.680 | +4.02% | 30,918 |
| 26-10-14 | $1.615 | -8.76% | 46,370 |
| 26-10-13 | $1.770 | -6.84% | 69,180 |
| 26-10-12 | $1.900 | +25.00% | 441,028 |
| 26-10-09 | $1.520 | +12.59% | 2,972,218 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PCSA Stock
Select your edition
All financial news and data tailored to specific country editions
